[
    [
        {
            "time": "2018-01-31",
            "original_text": "Drug/Biotech Stocks Q4 Earnings Due on Jan 31: LLY & VRTX",
            "features": {
                "keywords": [
                    "Drug/Biotech",
                    "Q4",
                    "Earnings",
                    "LLY",
                    "VRTX"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Drug/Biotech Stocks Q4 Earnings Due on Jan 31: LLY & VRTX",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-01-31",
            "original_text": "Eli Lilly’s 4Q17 Estimates: Human Pharmaceuticals Business",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "4Q17",
                    "Estimates",
                    "Human Pharmaceuticals"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly’s 4Q17 Estimates: Human Pharmaceuticals Business",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-01-31",
            "original_text": "Pre-Market Earnings Report for January 31, 2018: BA, LLY, TMO, ANTM, EPD, ADP, SPG, JCI, SIRI, IR, ERIC, WEC",
            "features": {
                "keywords": [
                    "Pre-Market",
                    "Earnings",
                    "BA",
                    "LLY",
                    "TMO",
                    "ANTM",
                    "EPD",
                    "ADP",
                    "SPG",
                    "JCI",
                    "SIRI",
                    "IR",
                    "ERIC",
                    "WEC"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "diverse"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pre-Market Earnings Report for January 31, 2018: BA, LLY, TMO, ANTM, EPD, ADP, SPG, JCI, SIRI, IR, ERIC, WEC",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-01-31",
            "original_text": "Eli Lilly’s 4Q17 Estimates: Revenue Growth Expected",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "4Q17",
                    "Revenue Growth",
                    "Expected"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly’s 4Q17 Estimates: Revenue Growth Expected",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-01-31",
            "original_text": "Analysts’ Estimates for Eli Lilly’s 4Q17 Earnings",
            "features": {
                "keywords": [
                    "Analysts",
                    "Estimates",
                    "Eli Lilly",
                    "4Q17",
                    "Earnings"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Analysts’ Estimates for Eli Lilly’s 4Q17 Earnings",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]